Julian Symons A.'s most recent trade in Aligos Therapeutics Inc was a trade of 23,310 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 23,310 | 23,310 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 21,693 | 21,693 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 10,880 | 10,880 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 72,000 | 72,000 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Symons Julian A. | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2024 | 200,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | A. Julian Symons | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2024 | 105,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Symons Julian A. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 74,998 | 74,998 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Symons Julian A. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 58,822 | 58,822 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian Symons A. | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2024 | 26,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Symons A. Julian | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 18,750 | 18,750 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 78,750 | 78,750 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 105,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Julian A. Symons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 26,250 | 26,250 | - | - | Stock Option (Right to Buy) |